androstenedione has been researched along with benzofurans in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, M; Delgado, PO; Nicholls, PJ; Perez, SF; Simons, C; Smith, HJ; Vinh, TK; Walters, HM | 1 |
| Criscuoli, M; Lippi, A; Maggi, CA; Mauro, S; Muratori, M; Palma, C | 1 |
| Bigioni, M; Cirillo, R; Criscuoli, M; Iafrate, EM; Lippi, A; Lopez, G; Maggi, CA; Maggi, M; Mancina, R; Muratori, M | 1 |
3 other study(ies) available for androstenedione and benzofurans
| Article | Year |
|---|---|
1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Benzofurans; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Ketones; Placenta; Pregnancy; Structure-Activity Relationship; Tetrazoles; Triazoles | 1999 |
Effect of the aromatase inhibitor, MEN 11066, on growth of two different MCF-7 sublines.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Benzofurans; Cell Division; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrone; Female; Humans; Microsomes; Placenta; Stereoisomerism; Testosterone; Triazoles; Tritium; Tumor Cells, Cultured | 2000 |
Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Benzofurans; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gonadotropins, Equine; Humans; Liver; Mixed Function Oxygenases; Organ Size; Ovary; Placenta; Rats; Rats, Wistar; Steroids; Triazoles; Uterus | 2003 |